Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage

By Liao Jun  

Human Molecular Genetics, Vol. 13, Iss. 15, 2004-08 ,pp. : 1577-1585

Oxford University Press

Access to resources Recommend Favorite

Isolation of a New Clathrin Heavy Chain Gene with Muscle-Specific Expression from the Region Commonly Deleted in Velo-cardio-facial Syndrome

By Sirotkin Howard  

Human Molecular Genetics, Vol. 5, Iss. 5, 1996-01 ,pp. : 617-624

Oxford University Press

Access to resources Recommend Favorite

Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments

By Paylor R.  

Human Molecular Genetics, Vol. 10, Iss. 23, 2001-11 ,pp. : 2645-2650

Oxford University Press

Access to resources Recommend Favorite

Recovery from arterial growth delay reduces penetrance of cardiovascular defects in mice deleted for the DiGeorge syndrome region

By Lindsay E.A.   Baldini A.  

Human Molecular Genetics, Vol. 10, Iss. 9, 2001-04 ,pp. : 997-1002

Oxford University Press

Access to resources Recommend Favorite

Catatonia in an adolescent with velo‐cardio‐facial syndrome

By  

American Journal Of Medical Genetics Part A, Vol. 167, Iss. 9, 2015-09 ,pp. : 2150-2153

John Wiley & Sons Inc

Access to resources Recommend Favorite